Hanif M, Hays AG, Nagarajan JS, Sah SP, Weinstock RS, Taub CC
Reduced appetite and food intake over months to years can lead to deficiencies in protein, iron, calcium, vitamin D, and B vitamins
Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein
Variants in GIPR, and FTO genes can provide context for how your body processes GLP-1 medications, potentially affecting treatment consistency and adjustment timing
Balance between on- and off-target effects of the dual GLP1/E agonist, and the concurrence of desensitization at very high doses, might contribute to this phenomenon
By activating GLP-1 receptors in the brain, Ozempic stimulates insulin release, slows down digestion, curbs appetite, and enhances satiety